10 robotic exoskeleton pilots transforming post-stroke hemiplegia care in 2026

The dawn of 2026 has brought a decisive shift in neuro-rehabilitation protocols as the Ministry of Health and Family Welfare in India initiates large-scale trials for wearable robotic systems. These pilots aim to address the chronic mobility deficits associated with unilateral paralysis by integrating machine-learning sensors that predict user intent. Unlike previous iterations, these 2026 models are designed for domestic environments, moving beyond the confines of specialized clinics to provide continuous therapeutic intervention in the patient’s own home.

Decentralizing neuro-rehabilitation through wearable tech

The transition toward decentralized care is a cornerstone of 2026 healthcare policy. By utilizing advanced sensors, healthcare providers can now monitor gait progress remotely, ensuring that the intensity of the physical therapy matches the neurological recovery of the patient. This approach is significantly reducing the burden on tertiary care centers, allowing specialized therapists to manage larger patient cohorts through digital dashboards while the robotic suits handle the repetitive, high-volume movements necessary for neuroplasticity.

Neural interface synchronization in modern mobility aids

A major breakthrough reported in early 2026 involves the synchronization of robotic limbs with non-invasive brain-computer interfaces. By reading electroencephalogram signals, these devices can initiate movement precisely when the patient "thinks" of a step. This timing is critical; it strengthens the synaptic connections between the brain and the affected limb. Clinical observations suggest that this synchronous firing is the most effective way to manage hemiplegia market interventions, leading to faster functional gains than traditional passive stretching.

Policy shifts toward reimbursed home-use devices

International regulatory bodies, including those in the UK and Germany, have updated their reimbursement frameworks for 2026 to include home-based robotic orthotics. This policy change recognizes the long-term cost-efficiency of preventing secondary complications like muscle atrophy and joint contractures. By providing patients with the tools to maintain mobility independently, public health systems are seeing a decline in readmission rates for stroke-related secondary ailments, signaling a more sustainable financial model for long-term disability management.

Global collaboration on assistive device standards

As we move through 2026, the Global Rehabilitation Alliance has proposed new safety and interoperability standards for all mobility-enhancing technologies. These standards ensure that data collected by an exoskeleton in South America can be analyzed by a neurologist in Europe using standardized metrics. This level of global data harmonization is accelerating the refinement of rehabilitation algorithms, ensuring that the next generation of assistive tech is optimized for diverse physiological profiles and varied environmental conditions across different continents.

Trending news 2026: Why your physical therapist might be a robot next year

Thanks for Reading — Discover how real-time biofeedback is turning the dream of independent living into a daily reality for thousands.

7 innovative gene therapy trials for pediatric hemiplegia launching in 2026

The commencement of 2026 marks a historic turning point for pediatric neurology as clinical investigators begin enrolling participants for CRISPR-based interventions targeting congenital hemiparesis. These trials, largely concentrated in advanced molecular centers across North America and East Asia, are moving beyond symptomatic relief to address the underlying genetic predispositions for early-onset neurological deficits. For the first time, researchers are investigating whether viral-vector delivery of neurotrophic factors can stimulate brain repair in children before the critical window of neuroplasticity closes.

Targeting the molecular roots of early motor loss

Current research in 2026 is pivoting toward the identification of specific biomarkers that predict how a child will respond to regenerative therapies. By analyzing the epigenetic landscape of neural stem cells, scientists can now tailor the viral load of gene therapies to minimize adverse reactions. This precision ensures that the therapeutic proteins are expressed only in the regions of the motor cortex affected by prenatal or perinatal injury, potentially restoring the neural pathways necessary for bilateral coordination.

Regulatory fast-tracking for pediatric rare diseases

In response to the urgent need for pediatric solutions, the FDA and EMA have implemented a harmonized "Fast-Track 2026" protocol for gene-editing platforms. This collaborative regulatory environment allows for the sharing of safety data in real-time, drastically reducing the time it takes for a candidate therapy to move from Phase I to Phase II. This is particularly vital for hemiplegia market participants focused on the pediatric niche, where early intervention can prevent a lifetime of secondary musculoskeletal complications.

Ethical frameworks for neonatal genetic intervention

As these trials progress in 2026, a global committee of bioethicists has convened to establish rigorous guidelines for genetic editing in minors. The focus remains on informed parental consent and the long-term tracking of "off-target" effects. These 2026 guidelines mandate that any child receiving gene therapy must be enrolled in a multi-decade observational study to ensure that the intervention does not interfere with normal developmental milestones or increase the risk of late-onset malignancies.

Economic implications of curative versus palliative care

Economists specializing in healthcare are closely watching the 2026 trial results to model the long-term impact on public health budgets. While the upfront cost of gene therapy is substantial, the potential to "cure" a lifelong disability offers immense savings by eliminating decades of physical therapy, orthotics, and lost productivity. Policy discussions in late 2026 are increasingly centered on "value-based" payment models, where manufacturers are reimbursed based on the functional independence achieved by the patient over a five-year period.

Trending news 2026: Is the end of lifelong physical therapy finally in sight?

Thanks for Reading — Follow our coverage as these molecular milestones redefine what is possible for the next generation of neurological health.

5 neuro-navigation breakthroughs redefining surgical intervention for hemiplegia in 2026

By mid-2026, the landscape of neurosurgery has been fundamentally altered by the introduction of real-time intraoperative functional mapping. Surgeons are now utilizing holographic overlays that visualize white matter tracts during procedures to treat lesion-induced paralysis. This technological leap allows for unprecedented precision in removing tumors or vascular malformations while preserving the delicate pathways responsible for motor control. These advancements are particularly critical for patients whose hemiplegia stems from focal cortical injuries, offering a chance at functional restoration that was previously deemed impossible.

Augmented reality in the neurosurgical suite

The 2026 surgical environment integrates augmented reality (AR) directly with robotic-assisted arms. This "smart-guidance" system alerts surgeons if they are within millimeters of a critical nerve bundle, using haptic feedback to prevent accidental damage. The ability to see "through" the brain tissue using pre-operative MRI data mapped onto the live surgical field has reduced the duration of complex neuro-interventions by nearly 25%, leading to better post-operative outcomes and fewer complications related to anesthesia.

Minimally invasive approaches to cortical stimulation

Recent breakthroughs in 2026 have also focused on the implantation of micro-electrode arrays via burr-hole surgeries rather than full craniotomies. These arrays are designed to bypass damaged cortical areas, sending signals directly to the spinal cord. This research is a pivotal part of the hemiplegia market focus on neuromodulation, where the goal is to provide a "neural bridge" for patients with severe motor deficits who have not responded to traditional rehabilitation.

Real-time monitoring of neuroplasticity during recovery

Post-surgical care in 2026 now includes the use of "smart" sutures and implants that can monitor the local chemical environment of the brain. These sensors track levels of lactate and oxygen, providing early warning signs of ischemia or inflammation before physical symptoms manifest. By intervening pharmacologically at the first sign of distress, medical teams can protect the brain's inherent ability to rewire itself, a process known as neuroplasticity, which is essential for regaining limb function after surgery.

Global access to specialized neuro-centers

A new initiative launched in 2026 by the World Federation of Neurosurgical Societies aims to establish "Centers of Excellence" in developing nations. These hubs are equipped with tele-robotics, allowing world-class surgeons in London or Tokyo to assist local teams in Mumbai or Nairobi during complex paralysis-reversal procedures. This democratization of surgical expertise is ensuring that the cutting edge of 2026 neuro-technology is accessible to patients regardless of their geographical location, bridging the gap in global healthcare equity.

Trending news 2026: Surgeons are now using holograms to fix the human brain

Thanks for Reading — Stay tuned as we explore how the fusion of robotics and human intent is creating a new era of surgical precision.

12 digital twin protocols optimizing hemiplegia therapy in 2026

The first quarter of 2026 has witnessed the widespread adoption of "Digital Twin" technology in rehabilitative medicine. By creating a high-fidelity virtual replica of a patient’s musculoskeletal and nervous systems, clinicians can now simulate different physical therapy regimens before they are ever performed on the patient. This predictive modeling is allowing for a hyper-personalized approach to treatment, ensuring that every exercise is optimized for the specific biomechanical constraints and neural recovery potential of the individual, significantly accelerating the return to functional independence.

Modeling the neural pathways for precision recovery

The 2026 Digital Twin models incorporate real-time data from wearable sensors and periodic MRI scans. This allows the software to map the "functional connectivity" of the brain—the way different regions communicate. For a patient with motor deficits, the model can identify which alternative neural pathways are most likely to take over the function of the damaged areas. This insight is transforming the hemiplegia market toward a software-first approach where data dictates the frequency and type of therapeutic intervention.

Virtual stress testing for orthopedic interventions

Beyond neurological mapping, these digital replicas are being used in 2026 to plan orthopedic surgeries associated with paralysis, such as tendon transfers. Surgeons can "test" the surgical outcome in the virtual world, assessing how a transferred muscle will affect gait or arm reach. This reduces the trial-and-error nature of complex reconstructive procedures, ensuring that the first surgery is the only one required and that the tension and placement of the graft are perfect for the patient's unique anatomy.

AI-driven adaptation of rehabilitation games

Gamified rehabilitation is seeing a massive upgrade in 2026 through AI integration. The Digital Twin communicates directly with VR rehabilitation platforms, adjusting the difficulty of the "game" in real-time based on the patient's predicted fatigue levels and muscle recruitment patterns. If the model detects that a patient is overcompensating with their healthy side, the game environment can subtly shift to force the engagement of the hemiplegic limb, ensuring that the therapy remains effective and safe throughout the session.

Data privacy and the ethics of the virtual self

As these virtual models become more complex in 2026, the question of data ownership has come to the forefront. Global health ministries are developing strict "Digital Bio-Data" laws to ensure that a person's digital twin cannot be accessed by insurers or employers without explicit consent. These laws recognize the digital twin as an extension of the physical body, requiring the same level of protection as medical records. This ethical framework is essential for maintaining patient trust as the medical community moves toward a fully digitized future.

Trending news 2026: Your digital double might save your life in the hospital

Thanks for Reading — Learn why the fusion of data science and biology is making the one-size-fits-all approach to medicine obsolete.

8 novel neuro-rehabilitation drugs entering Phase III trials in 2026

The pharmaceutical landscape of 2026 is undergoing a paradigm shift from purely symptomatic management to "neuro-regenerative" pharmacology. Researchers are now testing a new class of small molecules designed to cross the blood-brain barrier and stimulate the production of brain-derived neurotrophic factor (BDNF). These drugs are intended to be administered alongside intensive physical therapy for patients with unilateral paralysis, potentially creating a synergistic effect where the drug primes the brain for learning, and the therapy provides the necessary sensory input to guide that learning.

Stimulating synaptic growth through pharmacological priming

In early 2026, the focus has centered on "synaptogenic" compounds that help restore the connection between the brain and the spinal cord. These drugs target the extracellular matrix, which often acts as a physical barrier to nerve regeneration after a stroke or traumatic injury. By temporarily softening this matrix, the new drugs allow for the sprouting of new nerve endings. This biological breakthrough is a major driver in the hemiplegia market, as it moves the field closer to a biological solution for chronic motor loss.

Addressing the inflammatory cascade in sub-acute stroke

Another promising avenue in 2026 involves anti-inflammatory biologics that can be administered in the sub-acute phase of recovery—days or weeks after the initial injury. These therapies aim to "quench" the secondary wave of inflammation that often causes more damage than the initial stroke itself. By protecting the "penumbra"—the area of the brain that is damaged but not yet dead—these drugs can significantly limit the eventual degree of paralysis a patient experiences, making the subsequent rehabilitation much more effective.

Personalized dosing via real-time biomarker tracking

2026 has introduced the use of bio-electronic sensors that can detect drug concentrations in a patient's sweat or interstitial fluid. This allows for "dynamic dosing," where the medication levels are adjusted throughout the day to match the patient’s activity levels and circadian rhythms. For neuro-rehab drugs, this ensures that peak concentration coincides exactly with the patient's most intensive physical therapy sessions, maximizing the neuroplastic benefit while minimizing systemic side effects like nausea or fatigue.

Global regulatory standards for neuro-restorative agents

The International Council for Harmonisation (ICH) has released new 2026 guidelines for the testing of neuro-restorative drugs. These guidelines emphasize functional endpoints—such as the ability to perform activities of daily living—over simple neurological scores. This shift ensures that any drug approved for the market has a tangible, positive impact on the patient's quality of life. This regulatory clarity is encouraging more investment in the space, as manufacturers now have a clear roadmap for what constitutes a successful clinical trial in the realm of paralysis recovery.

Trending news 2026: The pill that helps you learn to walk again is almost here

Thanks for Reading — Discover how the next generation of pharmacology is turning the brain into a fertile ground for recovery.

15 pediatric neuro-plasticity clinics opening in India during 2026

The Indian healthcare landscape in 2026 is undergoing a major expansion in specialized pediatric services, with the launch of several "Neuro-Growth" centers across Tier-1 and Tier-2 cities. These clinics are specifically designed to treat hemiplegia and other motor impairments in children using a multi-disciplinary approach that combines intensive therapy, nutritional support, and early-intervention social programs. This initiative is part of a broader government push to reduce the long-term disability burden by treating neurological conditions during the first five years of life, when the brain is at its most adaptable.

Community-based models for rural neuro-intervention

A key feature of the 2026 expansion is the "Hub-and-Spoke" model, where major city clinics support smaller, community-run centers in rural areas. Local health workers are being trained in "Constraint-Induced Movement Therapy" (CIMT), a technique where the child’s healthy limb is temporarily restrained to force the use of the affected side. This low-cost, high-impact intervention is being integrated into the hemiplegia market as a sustainable way to bring world-class rehabilitation to underserved populations without requiring expensive equipment.

Integrating nutritional neuroscience into pediatric care

The 2026 clinics are the first to incorporate "Nutri-Neuro" protocols, which focus on providing specific fats and proteins essential for the formation of myelin—the insulating layer around nerves. Research conducted in early 2026 suggests that children who receive targeted nutritional support alongside physical therapy show 30% faster improvement in fine motor skills compared to those who do not. This holistic approach recognizes that the brain requires specific building blocks to repair and grow new neural connections effectively.

Social integration and the role of peer support

Beyond physical recovery, the new 2026 centers are emphasizing the social well-being of children with unilateral paralysis. Group therapy sessions are designed as "play-labs," where children can interact with peers who face similar challenges. This helps reduce the stigma and isolation often associated with physical disabilities. Peer support groups for parents are also a central feature, providing a space for families to share resources and advocacy strategies, which is proving to be a vital component of successful long-term home-care management.

Scaling via digital health and tele-rehab platforms

To ensure the sustainability of these 15 new clinics, the 2026 initiative relies heavily on a centralized digital health platform. This platform allows therapists to track a child's progress through video analysis and AI-driven movement tracking. Parents can access therapy videos and schedule remote consultations through a simple smartphone app. This digital infrastructure is ensuring that the high standards of the metropolitan "Hub" clinics are maintained across all 15 locations, regardless of local staffing levels or geographical constraints.

Trending news 2026: India's new plan to help children with paralysis is going digital

Thanks for Reading — Learn how community care and high-tech medicine are merging to change the lives of thousands of families.

9 policy changes in 2026 driving affordable neuro-robotics across Europe

The European Union has entered 2026 with a series of landmark legislative updates aimed at making high-tech rehabilitation affordable for all citizens. The "Right to Restore" act mandates that all public health insurance providers must cover the cost of advanced neuro-robotic devices for patients with permanent motor deficits, including hemiplegia. This move is designed to shift the focus from lifetime disability payments to one-time investments in restorative technology, reflecting a broader 2026 trend of viewing healthcare as an economic enabler rather than a sunk cost.

Subsidies for small-scale robotic manufacturers

To ensure a diverse market and prevent monopolies, the EU’s 2026 policy includes substantial subsidies for small and medium enterprises (SMEs) developing specialized assistive tech. These grants are specifically targeted at companies that focus on "open-source" robotics, allowing for faster iteration and lower production costs. This is a significant development for the hemiplegia market, as it encourages the creation of modular systems where components can be swapped out or upgraded as the patient's needs change over time.

Mandatory interoperability for healthcare data

Another critical policy shift in 2026 is the requirement for all medical devices to use a unified data standard. This means that a robotic glove from a French startup must be able to communicate seamlessly with a monitoring app developed in Sweden. This interoperability allows clinicians to aggregate data from multiple devices to get a complete picture of a patient's recovery. It also prevents "vendor lock-in," where a patient is forced to use products from a single company because their data cannot be transferred elsewhere.

Standardized training for "Cyber-Therapists"

As robotic intervention becomes the norm in 2026, the European Commission has launched a standardized certification for physical therapists specializing in technology-assisted care. These "Cyber-Therapists" are trained not only in human anatomy but also in basic robotics and data analysis. This new professional designation ensures that the human element of rehabilitation remains central, even as the tools become more automated. It also provides a clear career path for healthcare workers looking to transition into the high-tech medical fields of the future.

The impact on the global supply chain

Europe's 2026 policy focus is already having a ripple effect on the global healthcare supply chain. Major manufacturers in the US and Asia are adjusting their production lines to meet the strict EU standards for repairability and data privacy. This is leading to a worldwide increase in the quality and durability of medical robotics. By setting a high bar for its own market, Europe is effectively raising the standard of care for patients with paralysis across the globe, driving a new era of high-quality, sustainable medical technology.

Trending news 2026: Why Europe's new health laws are making robot suits cheaper for everyone

Thanks for Reading — Discover how political will is turning science fiction into standard medical practice across the continent.

6 breakthroughs in non-invasive brain stimulation for hemiplegia in 2026

As 2026 progresses, the field of neuro-rehabilitation is being revolutionized by "Next-Gen" Transcranial Magnetic Stimulation (TMS). Unlike the bulky, clinic-bound machines of the past, 2026 has introduced portable, high-definition TMS caps that can be worn during daily activities. These devices use targeted electromagnetic pulses to "prime" the motor cortex, making it more responsive to the signals coming from the body. For patients with hemiplegia, this means that even a small amount of residual movement can be amplified into functional strength through repeated, stimulated practice.

Temporal interference and deep brain targeting

A major technical milestone reached in early 2026 is the use of "Temporal Interference" (TI) stimulation. This technique allows researchers to target deep brain structures—like the thalamus or basal ganglia—without affecting the outer layers of the brain. By using two high-frequency fields that intersect at a specific point, TI can stimulate the regions responsible for motor coordination that are often unreachable with traditional non-invasive methods. This is a game-changer for the hemiplegia market, offering hope for patients with deep-seated vascular injuries.

Closed-loop systems and real-time EEG feedback

Modern stimulation devices in 2026 are "closed-loop," meaning they don't just send signals; they also listen to the brain. By incorporating real-time electroencephalogram (EEG) sensors, these systems only provide a pulse when they detect that the patient is actively trying to move. This "intent-based" stimulation ensures that the brain's own electrical activity is reinforced, rather than simply overridden. Clinical trials in 2026 have shown that closed-loop systems lead to significantly more durable recovery than "open-loop" systems that stimulate at a fixed interval.

The transition from clinic to home-based stimulation

Regulatory approval for home-use neuro-stimulation in 2026 has opened the door for thousands of patients to continue their therapy outside of professional settings. These home devices are controlled via a smartphone app, which allows the therapist to prescribe specific stimulation patterns and monitor usage remotely. To ensure safety, the devices include built-in limiters that prevent over-stimulation and only function when the patient is in a rested state. This transition is making intensive neuro-rehab a reality for those who live far from specialized medical centers.

Psychological benefits of sensory restoration

Beyond motor gains, 2026 research is highlighting the profound psychological impact of restored sensory feedback. Many patients with unilateral paralysis also suffer from "neglect," where they lose the mental connection to the affected side of their body. Non-invasive stimulation of the parietal cortex is proving effective in "waking up" this mental map, allowing patients to feel more physically whole. This mental restoration is often the first step toward successful physical recovery, providing the motivation and focus needed for long-term rehabilitation.

Trending news 2026: The "thinking cap" that actually fixes your brain is finally here

Thanks for Reading — Explore how electromagnetic waves are bridging the gaps left by neurological injury.

11 global insurers updating hemiplegia coverage for long-term care in 2026

The insurance sector in 2026 is undergoing a major structural shift as providers move away from "catastrophic only" coverage toward integrated, long-term health management. In the first half of the year, eleven major international insurers announced updated policies that specifically include lifelong funding for adaptive equipment and home-based rehabilitation services for paralysis. This change is driven by a new 2026 consensus that providing early and continuous support is 40% more cost-effective over a decade than paying for institutional care and secondary medical complications.

Predictive risk modeling and preventive coverage

Using 2026's advanced data analytics, insurers can now predict which stroke survivors are at the highest risk of developing permanent paralysis. These high-risk individuals are being automatically enrolled in "Prevention Plus" programs that cover the cost of intensive neuro-rehab during the first 90 days after the event. By front-loading the investment in recovery, insurers are significantly reducing the likelihood of a claimant requiring lifelong disability support, a strategic move that is stabilizing premiums in the hemiplegia market segment.

Outcome-based reimbursement for therapy centers

A significant 2026 policy shift involves "Outcome-Based Care" (OBC), where rehabilitation clinics are reimbursed based on the functional improvement of the patient, rather than the number of sessions provided. To support this, insurers are funding the installation of standardized movement-tracking hardware in all partner clinics. This ensures that the data used to measure progress is objective and consistent across different providers, rewarding those clinics that achieve the best results for their patients and driving up the overall quality of care.

Coverage for "Smart-Home" neurological adaptations

For the first time, 2026 policies are extending coverage beyond medical devices to include "Smart-Home" modifications. This includes voice-activated controls, automated entry systems, and fall-detection sensors. Insurers now view these as essential medical necessities for patients with unilateral motor loss, as they allow for independent living and reduce the need for expensive home-health aides. This "aging-in-place" philosophy is a core part of the 2026 insurance mandate, reflecting a broader societal shift toward autonomy for people with disabilities.

The rise of "Health-Miles" incentive programs

Some insurers in 2026 have launched pilot programs that reward patients for completing their prescribed rehabilitation exercises. Patients who use connected wearable devices to track their gait or arm movement can earn "Health-Miles," which can be used to lower their monthly premiums or purchase additional wellness services. This gamification of recovery is proving highly effective in maintaining patient motivation over the months and years required for neurological healing, creating a win-win scenario for both the payer and the patient.

Trending news 2026: Why your insurance company now wants you to play video games

Thanks for Reading — Stay informed as the financial pillars of healthcare evolve to support a lifetime of neurological wellness.

4 emerging stem cell scaffolds for chronic hemiplegia recovery in 2026

By the third quarter of 2026, tissue engineering has reached a critical milestone with the successful implantation of bio-synthetic scaffolds designed to support nerve regrowth in the brain. These "scaffolds" are 3D-printed structures infused with neural stem cells and growth factors, placed directly into the cavity left by a stroke or injury. Unlike older cell therapies, which often failed because the cells would not stay in place, these 2026 scaffolds provide a stable environment for the new cells to integrate with the patient's existing neural network, offering a tangible path to recovery for those with chronic motor deficits.

Bio-printing and the customization of neural tissue

A key advancement in 2026 is the ability to print these scaffolds using a patient's own cells, virtually eliminating the risk of rejection. Modern bio-printers can replicate the complex, porous structure of brain tissue, allowing for the correct flow of nutrients and signals. This level of customization is a primary focus for the hemiplegia market, as it allows surgeons to match the scaffold exactly to the size and shape of the patient's brain lesion, ensuring the best possible fit and functional integration.

Optogenetic control of implanted neural networks

In a futuristic development for late 2026, some of these scaffolds are being designed with "optogenetic" capabilities. This involves modifying the implanted stem cells so they can be activated by light. By using a tiny, implanted LED fiber, therapists can "train" the new nerves to fire at specific times, helping them integrate more quickly into the motor pathways. This precise control over the new tissue’s activity is proving to be far more effective than simply letting the cells grow on their own, drastically reducing the time needed for functional recovery.

Addressing the ethical landscape of brain tissue engineering

As we move through 2026, the global scientific community is engaged in deep debate regarding the ethical implications of creating "hybrid" brain tissue. New international guidelines mandate that these scaffolds must be strictly focused on motor restoration and cannot be used to enhance cognitive abilities beyond a patient's baseline. These 2026 regulations are essential for maintaining public trust in regenerative medicine, ensuring that the technology is used solely for the relief of suffering and the restoration of lost function.

Preparing for large-scale clinical rollout

With several successful 2026 pilot studies nearing completion, major biomedical hubs are preparing for a wider rollout of stem cell scaffolding by early 2027. This involves scaling up the production of specialized "bio-inks" and training neurosurgeons in the delicate implantation techniques required. The goal is to move this from a specialized experimental procedure to a standard option for anyone living with the long-term effects of unilateral paralysis, fundamentally changing the prognosis for neurological injury worldwide.

Trending news 2026: Science is now 3D-printing the parts of the brain that help you move

Thanks for Reading — Join us as we track the frontier where biology and engineering meet to rewrite the human story.